The global combination drugs diagnostic maket size was USD 17.28 Billion in 2022 and is projected to reach USD 34.54 Billion by 2032, registering a rapid revenue Compound Annual Growth Rate (CAGR) of 8% during the forecast period. A key driver of market revenue growth is the escalating prevalence of chronic diseases such as cancer, heart disease, and diabetes. According to the World...